Medics hail new era in battle against ageing
LinkGevity's first-in-class Anti-Necrotic drug was featured in the Sunday Express this week. The article highlights the transformative potential of targeting necrosis- a long-overlooked driver of age-related degeneration.
As the world faces a rapidly growing ageing population, the burden on health systems, economies and families is accelerating. The need for solutions that preserve organ function and extend healthy years has never been more urgent.
Professor Justin Stebbing (Imperial) said:
Necrosis sounds like a biology term, but what it really means is tissue rot...If you can prevent that, you don’t just look younger - your organs actually stay younger.
Dr Carina Kern, LinkGevity CEO said:
The body is an interconnected network. We’re not just targeting a symptom - we’re targeting the process that drives ageing itself.
